Key facts
- This page summarizes John Kenneth Paglia's Form 4 filing for SPLASH BEVERAGE GROUP, INC. (SBEV).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 07 Mar 2024, 17:30.
John Kenneth Paglia - 26 Feb 2024 Form 4 Insider Report for SPLASH BEVERAGE GROUP, INC. (SBEV)
- Reporting relationship
- Director
- Issuer ticker
- SBEV
- Reported as of
- 26 Feb 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 07 Mar 2024, 17:30:37 UTC
- Prior SEC filing
- 02 Feb 2024
- Next SEC filing
- 02 May 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ John Paglia
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John Kenneth Paglia filed Form 4 for SPLASH BEVERAGE GROUP, INC. (SBEV) on 07 Mar 2024.
Change
- Previous filing in this sequence was filed on 02 Feb 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SBEV
transaction
Derivative
Stock options
Award
- Transaction value
- $0
- Shares
- +600,000
- Change %
- Price
- $0.000000
- Shares after
- 600,000
- Date
- 26 Feb 2024
- Ownership
- Direct
- Underlying class
- Common stock
- Underlying amount
- 600,000
- Exercise price
- $0.5275
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The options were issued in connection with serving as a director on SBEV's board, pursuant to the 2020 Long-Term Incentive Compensation Plan. The options are subject to the following vesting schedule: (i) 200,000 shares vested upon execution of Dr. Paglia's offer letter, and (ii) the remaining 400,000 shares vesting 50,000 per quarter beginning May 23, 2024, and ending February 25, 2026. Should there be a change in control of the Company, the options will all immediately vest.
Footnote F2
Dr. Paglia's shares remain subject to termination in the event Dr. Paglia chooses to resign during the first 90 days of his tenure.
Footnote F3
The expiration date of the options is fixed at 2/26/2034 and is unaffected whether or not Dr. Paglia is engaged with the Company.